Kenneth B. Kirby

Board of Directors, Director

Ken has pioneered transdermal delivery since 1990 and is the co-inventor of the TDSC technology. He is also the founder and Managing Director of Langford Research Institute. In 2001, Ken started a research collaboration with the William Harvey Research Institute at St. Bartholomew's and Queen Mary's Medical College, University of London. Ken holds a B.A. in pre-medical studies from Florida State University. He is a member of Phi Beta Kappa and the American Chemical Society.

Meet More of Our Team
InsuLife is a Norwegian company aiming at bringing the unparalleled developmental INS-2301 spray-based insulin to market.
Learn More
© Copyright 2023 - InsuLife AS, All Rights Reserved
cross